ArticleJournal of bioenergetics and biomembranes2021

GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.

Mei Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.